NCT00001210View on ClinicalTrials.gov

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

CompletedOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

November 30, 1986

Study Completion Date

September 30, 2000

Conditions

HIV InfectionsHealthy

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH